Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease

Li Ting Ho, Lian Yu Lin, Yao Hsu Yang, Cho Kai Wu, Jyh Ming Jimmy Juang, Yi Chih Wang, Chia Ti Tsai, Ling Ping Lai, Juey Jen Hwang, Fu Tien Chiang, Jiunn Lee Lin, Pau Chung Chen

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)


Objectives The objective is to assess the effectiveness of statin use to prevent atrial fibrillation (AF) in dialysis patients. Methods We used a database from the Registry for Catastrophic Illness from the National Health Research Institute (NHRI), which encompasses almost 100% of the patients receiving dialysis started from 1997 to 2008 in Taiwan. All dialysis patients aged 18 or older without history of cardiovascular events in 1997 and 1998 were incorporated. Finally, 113,191 dialysis patients were enrolled. We used propensity score (PS) matching method and Cox's proportional hazard regression models to estimate hazard ratios for AF events for statin users vs. nonusers. Results In statin group, the incidence of developing new AF was significantly lower than that in control group (1.1% vs. 3.8%, P < 0.001). The PS-based selection process identified 2146 patients receiving statins and 2146 who did not receive statins. The incidence of developing AF remained lower in statin group than that in control group (2.4% vs. 4.9%, P < 0.001). After PS matching, Cox's proportional hazard regression analyses showed that there was a protective effect of developing AF in a dose-responsive manner. The protective effect was more obvious in subjects with younger age, female gender, hyperlipidemia, coronary artery disease and peripheral artery disease and in subjects without taking angiotensin converting enzyme inhibitor and angiotensin receptor blocker. Conclusion Our analyses showed that statin therapy was associated with lower risk of newly diagnosed AF in patients with dialysis.
頁(從 - 到)538-543
期刊International Journal of Cardiology
出版狀態已發佈 - 10月 10 2015


  • Atrial fibrillation
  • Dialysis
  • Propensity score
  • Statins

ASJC Scopus subject areas

  • 心臟病學與心血管醫學


深入研究「Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease」主題。共同形成了獨特的指紋。